SILVERBACK ASSET MANAGEMENT LLC - IBERE PHARMACEUTICALS ownership

Back to all holdings Add to watchlist

IBERE PHARMACEUTICALS's ticker is IBER and the CUSIP is G46843101. A total of 48 filers reported holding IBERE PHARMACEUTICALS in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
SILVERBACK ASSET MANAGEMENT LLC ownership history of IBERE PHARMACEUTICALS
ValueSharesWeighting
Q4 2022$302,700
+1.8%
30,0000.0%0.04%0.0%
Q3 2022$297,300–30,000–0.04%–
 Download
Other shareholders
IBERE PHARMACEUTICALS shareholders Q4 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IBERE PHARMACEUTICALS shareholders